Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake

References

• Adams DO. Macrophages. Method Enzymol 1979; 58: 494–506
   PubMedGoogle Scholar
• Antonsen KP, Hoffman AS. Water structure of PEG solutions by differential calorimetry measurements. Poly(ethylene glycol) chemistry: Biotechnical and biomedical applications, JM Harris. Plenum Press, New York 1992; 15–27
   Google Scholar
• Cao EH, Liu XQ, Wang JJ, Xu NF. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med 1996; 20: 801–806
   PubMed Web of Science ®Google Scholar
• Coleman DL, Gregonis DE, Andrade JD. The minimum interfacial free energy and optimum polar/apolar ratio hypothesis. J Biomed Mater Res 1982; 16: 381–398
   PubMed Web of Science ®Google Scholar
• Dunn SE, Coombes AGA, Garnett MC, Davis SS, Martyn C, Davies MC, Illum L. In vitro cell interaction and in vivo distribution of poly (lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J Cont Rel 1997; 44: 65–76
   Web of Science ®Google Scholar
• Faers MA, Luckham PF. Rheology of polyethylene oxide-polypropylene oxide block copolymer stabilized latices and emulsions. Colloids Surfaces A: Physicochem Eng Aspects 1994; 86: 317–327
   Google Scholar
• Feng M, Pan SR, Zhang JX, Wang QM, Wu WR, Li RM. In vitro phagocytic uptake of PEG-PBLG nanoparticles containing amphotericin B. J China Pharm Univ 2005; 36: 321–325
   Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55: R1–R4
   Web of Science ®Google Scholar
• Frank M, Fries L. The role of complement in inflammation and phagocytosis. Immunol Today 1991; 12: 322–326
   PubMedGoogle Scholar
• Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Chosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000; 202: 1–10
   PubMed Web of Science ®Google Scholar
• Giacomo F, Mariano L, Silvana M, Domenico S, Gaetano G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001; 22: 2857–2865
   PubMed Web of Science ®Google Scholar
• Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr Drug Metab 2007; 8: 137–149
   PubMed Web of Science ®Google Scholar
• Illum L, Davis SS. The effect of hydrophilic coatings on the uptake of colloidal particles with mouse peritoneal macrophages. Int J Pharm 1986; 29: 53–65
   Web of Science ®Google Scholar
• Illum L, Davis SS, Wilson CG, Thomas NW, Frier M, Hardy JG. Blood clearance and organ deposition of intravenously administered colloidal particles. The effect of particle size, nature and shape. Int J Pharm 1982; 12: 135–146
   Web of Science ®Google Scholar
• Litzinger DC, Buiting AM, Rooijen N, Leaf H. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic PEG poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1994; 1190: 99–107
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang CG, Zhong ZR, Zhang ZR. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 2007; 340: 153–162
   PubMed Web of Science ®Google Scholar
• Luo YF, Chen DW, Ren LX, Zhao XL, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Cont Rel 2006; 114: 53–59
   PubMed Web of Science ®Google Scholar
• Malmsten M, Linse P, Cosgrove T. Adsorption of PEO-PPO-PEO block copolymers at silica. Macromolecules 1992; 25: 2474–2481
   Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles. Production characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–196
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Muir IS, Illum L, Davis SS, Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1993; 1179: 157–165
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Patel HM. Serum factors that regulate phagocytosis of liposomes by Kupffer cells. Biochem Soc Trans 1993; 21: 128S
   Google Scholar
• Nagaoka S, Mori Y, Tanzawa H, Nishiumi S. Interaction between blood components and hydrogels with poly(oxythylene) chains. Polymers as biomaterials, SW Shalaby, AS Hofman, DB Ratner, T Horbett. Plenum Press, New York 1984; 361–374
   Google Scholar
• Olbrich C, Kayser O, Kiderlen AF, Müller RH. Flow cytometry as a possible tool for assessing cellular binding capacities of solid lipid particles (SLN). Proceedings 26th International Symposium on Controlled release of Bioactive Materials. Boston, MA 20–23 June, 1999; 519–520, 1999
   Google Scholar
• Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 1995; 16: 195–214
   Web of Science ®Google Scholar
• Su ZR, Liu ZQ, Zhou H. Change of chemical composition of tashinone in concentration and drying technology (1)—degradation mechanism of Tashinone IIA under the heat and moisture. Chin Trad Patent Med 1997; 19: 5–6
   Google Scholar
• Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev 2001; 50: 3–20
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988; 9: 356–362
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci 1990; 94: 107–141
   Web of Science ®Google Scholar
• Wang JX, Sun X, Zhang ZR. Enhanced brain targeting by synthesis of 3’,5’-dioctanoyl-5-fluoro-2’-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm 2002; 54: 285–290
   PubMed Web of Science ®Google Scholar
• Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, Wang W. Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 2005; 116: 799–807
   PubMed Web of Science ®Google Scholar
• Yuan SL, Wang XJ, Wei YQ. Anticancer effect of tanshinone and its mechanisms. Ai Zheng 2003; 22: 1363–1366
   PubMedGoogle Scholar
• Zhao BL, Jiang W, Zhao Y, Hou JW, Xin WJ. Scavenging effects of Savia miltiorrhiza on free radical and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int 1996; 38: 1171–1182
   PubMedGoogle Scholar
• Zhigaltsev IV, Maurerb N, Akhongb QF, Leoneb R, Lengb E, Wang JF, Sempleb SC, Cullis PR. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Cont Rel 2005; 104: 103–111
   PubMed Web of Science ®Google Scholar